US$ 27.82
what is semaglutide approved for FDA Approves Oral as the First Oral GLP-1 Pill FDA Warns on Certain Forms
Description
Addiction scholar Carolina Haass-Koffler offers insight on how and why these drugs work and their potential for revolutionizing addiction treatment.

Obesity is a chronic condition

Transformer-based models predominate, with BERT and its biomedical or tweet variants (e.g., RoBERTa, BioBERT, BERTweet) used in more than 60% of approaches

Zepbound saw a 14% increase since 2024, leaving 4.9 million people without coverage, and Ozempic saw a 22% increase, affecting another 1.1 million people.

Weight-loss drugs keep gaining traction - is that a blessing or a curse for the packaging industry

Understanding your genetic predispositions in peptide pathways may help inform more personalized conversations with your healthcare provider about treat...